BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36346027)

  • 1. Comprehensive treatment of basal cell carcinoma in nevoid basal cell carcinoma syndrome with 5-fluorouracil and salicylic acid.
    Yu Y; Zhang G; Fu S
    Dermatol Ther; 2022 Dec; 35(12):e15972. PubMed ID: 36346027
    [No Abstract]   [Full Text] [Related]  

  • 2. Urticaria after methyl aminolevulinate photodynamic therapy in a patient with nevoid basal cell carcinoma syndrome.
    Wolfe CM; Green WH; Hatfield HK; Cognetta AB
    J Drugs Dermatol; 2012 Nov; 11(11):1364-5. PubMed ID: 23135091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basal cell nevus syndrome. Unresponsiveness of early cutaneous lesions to topical 5-fluorouracil or dinitrochlorobenzene.
    Hazen PG; Taub SJ
    Dermatologica; 1984; 168(6):287-9. PubMed ID: 6745474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Photodynamic therapy for a nevoid basal cell carcinoma syndrome].
    Hanneken S; Sterzinger AA; Schulte KW; Reifenberger J
    Hautarzt; 2005 Apr; 56(4):363-4. PubMed ID: 15750676
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of daily dosing versus Monday through Friday dosing of vismodegib for locally advanced basal cell carcinoma and basal cell nevus syndrome: A retrospective case series.
    Wong C; Poblete-Lopez C; Vidimos A
    J Am Acad Dermatol; 2020 Jun; 82(6):1539-1542. PubMed ID: 32092372
    [No Abstract]   [Full Text] [Related]  

  • 6. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
    Itkin A; Gilchrest BA
    Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete basal cell carcinoma remission with imiquimod in a patient with nevoid basal cell carcinoma syndrome and associated basal cell carcinoma of the scalp and invasive ductal breast cancer.
    Quist SR; Franke I; Helmdach M; Kraus C; Reis A; Froster UG; Fehsecke D; Gollnick HP; Bonnekoh B
    J Am Acad Dermatol; 2011 Mar; 64(3):611-3. PubMed ID: 21315966
    [No Abstract]   [Full Text] [Related]  

  • 8. Basal cell carcinoma rebound after cessation of vismodegib in a nevoid basal cell carcinoma syndrome patient.
    Wolfe CM; Green WH; Cognetta AB; Hatfield HK
    Dermatol Surg; 2012 Nov; 38(11):1863-6. PubMed ID: 22805146
    [No Abstract]   [Full Text] [Related]  

  • 9. Photodynamic therapy for treatment of multiple lesions on the scalp in nevoid basal cell carcinoma syndrome: case report.
    Neves DR; Ramos DG; Magalhães GM; Rodrigues Rda C; Souza JB
    An Bras Dermatol; 2010; 85(4):545-8. PubMed ID: 20944918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nodular basal cell carcinoma in Gorlin's syndrome treated with systemic photodynamic therapy and interstitial optical fiber diffuser laser.
    Madan V; Loncaster JA; Allan D; Lear JT; Sheridan L; Leach C; Allan E
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S86-9. PubMed ID: 17052541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nevoid basal cell carcinoma syndrome successfully treated with trichloroacetic acid and phenol peeling.
    Kaminaka C; Yamamoto Y; Furukawa F
    J Dermatol; 2007 Dec; 34(12):841-3. PubMed ID: 18078412
    [No Abstract]   [Full Text] [Related]  

  • 12. Aromatic retinoid in the chemoprevention of the progression of nevoid basal-cell carcinoma syndrome.
    Cristofolini M; Zumiani G; Scappini P; Piscioli F
    J Dermatol Surg Oncol; 1984 Oct; 10(10):778-81. PubMed ID: 6491017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photodynamic therapy for basal cell carcinoma.
    Fargnoli MC; Peris K
    Future Oncol; 2015 Nov; 11(22):2991-6. PubMed ID: 26550910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hedgehog Pathway Inhibition for Locally Advanced Periocular Basal Cell Carcinoma and Basal Cell Nevus Syndrome.
    Ozgur OK; Yin V; Chou E; Ball S; Kies M; William WN; Migden M; Thuro BA; Esmaeli B
    Am J Ophthalmol; 2015 Aug; 160(2):220-227.e2. PubMed ID: 25935097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vismodegib in advanced basal-cell carcinoma.
    Henkin RI
    N Engl J Med; 2012 Sep; 367(10):970; author reply 970-1. PubMed ID: 22931271
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral hedgehog-pathway inhibitors for basal-cell carcinoma.
    Lear JT
    N Engl J Med; 2012 Jun; 366(23):2225-6. PubMed ID: 22670909
    [No Abstract]   [Full Text] [Related]  

  • 17. Sunscreen may prevent the development of basal cell carcinoma in individuals with basal cell carcinoma nevus syndrome: A retrospective survey study.
    Waldman RA; Grant-Kels JM
    J Am Acad Dermatol; 2019 Oct; 81(4):1028-1030. PubMed ID: 30928468
    [No Abstract]   [Full Text] [Related]  

  • 18. Etretinate treatment of the nevoid basal cell carcinoma syndrome. Therapeutic and chemopreventive effect.
    Hodak E; Ginzburg A; David M; Sandbank M
    Int J Dermatol; 1987 Nov; 26(9):606-9. PubMed ID: 3443534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporary arrest of basal cell carcinoma formation in a patient with basal cell naevus syndrome (BCNS) since treatment with a gel containing various plant extracts.
    Tjeerdsma F; Jonkman MF; Spoo JR
    J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):244-5. PubMed ID: 20500542
    [No Abstract]   [Full Text] [Related]  

  • 20. The nevoid basal cell carcinoma syndrome. Histopathology of the basal cell tumors.
    Lindeberg H; Jepsen FL
    J Cutan Pathol; 1983 Feb; 10(1):68-72. PubMed ID: 6841732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.